Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papilloma Virus Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT03887793
What this trial is testing

Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination in Integrated Healthcare Delivery Systems

Who this might be right for
Human Papillomavirus Infection
University of North Carolina, Chapel Hill
Large-scale testing (Phase 3)Study completedNCT00380367
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 110
Large-scale testing (Phase 3)Active Not RecruitingNCT04199689
What this trial is testing

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 6,033
Large-scale testing (Phase 3)Study completedNCT03979014
What this trial is testing

Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia

Who this might be right for
Neoplasia
Imperial College London 1,099
Post-approval studies (Phase 4)UnknownNCT05279248
What this trial is testing

The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Measles+2 more
Zhejiang Provincial Center for Disease Control and Prevention 300
Not applicableActive Not RecruitingNCT05065840
What this trial is testing

Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study

Who this might be right for
Human Papilloma VirusHuman Papilloma Virus Vaccine
Emory University 267
Post-approval studies (Phase 4)Looking for participantsNCT05672927
What this trial is testing

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

Who this might be right for
ImmunizationHPV InfectionHuman Papillomavirus
The University of Texas Medical Branch, Galveston 618
Testing effectiveness (Phase 2)WithdrawnNCT06142461
What this trial is testing

Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System

Who this might be right for
Vaccine Reaction
PharmaJet, Inc.
Post-approval studies (Phase 4)UnknownNCT05415345
What this trial is testing

Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Hepatitis E Virus Infection
Xiamen Innovax Biotech Co., Ltd 480
Large-scale testing (Phase 3)UnknownNCT01512784
What this trial is testing

Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults

Who this might be right for
HPVHIV
University of Milan 100
Post-approval studies (Phase 4)Active Not RecruitingNCT07281677
What this trial is testing

Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years

Who this might be right for
HPV Infection
Zhejiang Provincial Center for Disease Control and Prevention 400
Large-scale testing (Phase 3)UnknownNCT06207175
What this trial is testing

Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 1,260
Not applicableStudy completedNCT03000998
What this trial is testing

Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake

Who this might be right for
Human Papillomavirus VirusHPV
Klein Buendel, Inc. 432
Not applicableNot Yet RecruitingNCT07351604
What this trial is testing

Effectiveness of Large Language Model-Based Chatbot Among Female University Stdents in Improving HPV Vaccine Awareness, Intention and Vaccination Rates

Who this might be right for
HPV Vaccination RatesHPV Vaccine AwarenessHPV Vaccination Intention
Xiamen University 18,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT07256912
What this trial is testing

A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia

Who this might be right for
Vaccine EffectivenessHPV VaccinationSingle Dose+3 more
International Agency for Research on Cancer 1,266
Post-approval studies (Phase 4)Study completedNCT00925288
What this trial is testing

Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers

Who this might be right for
Human Papillomavirus Infection
Johns Hopkins Bloomberg School of Public Health 200
Not applicableNot Yet RecruitingNCT07530679
What this trial is testing

Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination

Who this might be right for
Cervical Cancer Prevention
Jiangsu Province Centers for Disease Control and Prevention 360
Early research (Phase 1)UnknownNCT02888418
What this trial is testing

Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17

Who this might be right for
Cervical Cancer
Beijing Chaoyang District Centre for Disease Control and Prevention 135
Large-scale testing (Phase 3)Study completedNCT00090220
What this trial is testing

Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)

Who this might be right for
Healthy Adult Female ParticipantsPreventionPapillomavirus Infection+1 more
Merck Sharp & Dohme LLC 3,819
Large-scale testing (Phase 3)Study completedNCT02733068
What this trial is testing

A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Cervical Intraepithelial Neoplasia
Shanghai Zerun Biotechnology Co.,Ltd 12,000
Next Page